insights_auto
Why is QDEL up 8.14%?
Dive Deeperchevron_right
QDEL:NASDAQ
Quidelortho Corp
$13.42
arrow_upward
+8.14%(+1.01) 1D
Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$12.52
High
$13.62
Low
$12.21
Mkt. cap
920.28M
Avg. vol.
1.59M
Volume
18.00
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
Open
$12.52
High
$13.62
Low
$12.21
Mkt. cap
920.28M
Avg. vol.
1.59M
Volume
18.00
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
News stories
From web sources and news partners
The Harvard Law School Forum on Corporate Governance
·
29 minutes ago
CEO and Executive Compensation Practices in the Russell 3000 and S&P 500: 2026
Barron's
·
22 minutes ago
Put the Bull Market’s 4th Birthday Celebrations on Hold
Investing.com
·
14 minutes ago
Dow Jones, Nasdaq, S&P 500 preview: Markets brace for CPI, Q3 earnings kick-off
Reuters
·
3 hours ago
Wall Street's big but narrow rally: 4 in 10 S&P stocks are down this year
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorMedical device
Websitequidelortho.com